Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07575620
Active, not recruiting Not applicable

The Effect of Blood Flow Restriction Training on Gait Performance on Forty Chronic Stroke Patients Evaluated by STEADYs Gait Assessment.

NCT07575620 · tracked via the Priya Life Science Egypt tracker
Sponsor
Cairo University
Phase
Not applicable
Started
2026-04-01
Last updated
2026-05-08

Condition(s) studied

Stroke Gait Rehabilitation

Investigational drug(s) / intervention(s)

Blood flow restriction trainingResistance Exercises for lower limb affected

Blood flow restriction training: Using BFRT combined with Resistance Exercises

Resistance Exercises for lower limb affected: Resistance Exercises using weights applied from different positions

Study summary

The goal of this observational study is to learn about the effects of blood flow restriction on gait performance on stroke patients. The main question it aims to answer is:

Is there a significant effect of blood flow restriction on gait performance on stroke patients?

Eligibility

Sex
ALL
Min age
40 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Chronic stroke patients more than 6 months. * Ages of the patients will range from 40 to 65 years. * The degree of spasticity ranged from 1 to 1+ grade (mild spasticity) according to the Modified Ashworth Scale. * Ability to walk 10 m. * Medically stable patients. Exclusion Criteria: * Patients with lower limb oedema. * Patients with disability in visual, auditory, and vestibular systems. * Resting systolic blood pressure\>160 mmHg or resting diastolic blood pressure\>100 mmHg. * Cognitive deficits preventing them from undergoing the assessments, exercise program or informed consent process. * Major neurological or musculoskeletal deficits from another diseases that could affect training. * Patients with lower limb deep vein thrombosis. * Patients who have any vascular problems.

Primary outcome measure(s)

  • The changes in gait performance — Pre study each patient will be included in the assessment as walking for 2 minutes wearing the IMU sensors and post study after 6 weeks
    Using STEADYS gait assessment system all patients will be assigned to measure the gait phases and gait parameters pre and post study to assess if there is differences.

Trial sites (1)

FacilityCityRegionStatus
Outpatient Clinics of faculty of physical therapy Cairo University Giza الجيزة

More Cairo University trials in Egypt

The Link Between Periodontitis, Smoking and Oral Cancer Starting soon
Treating Intrabony Defect With MINST VS MINST Extended PRF Recruiting
Respiratory Exercises Versus Deep Neck Flexor Training in Chronic Mechanical Neck Pain Recruiting
Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure Starting soon
Preparation Time Of Bioflx Crowns Compared To Zirconia Crowns On Primary Molars Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07575620 on ClinicalTrials.gov ↗ ← All trials in Egypt